Home
>
National Drug Code (NDC)
>
ethosuximide
ethosuximide - 68382-443-05 - (ethosuximide)
Drug Information of ethosuximide
| Product NDC: | 68382-443 |
| Proprietary Name: | ethosuximide |
| Non Proprietary Name: | ethosuximide |
| Active Ingredient(s): | 250 1/1 & nbsp; ethosuximide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ethosuximide
| Product NDC: | 68382-443 |
| Labeler Name: | Zydus Pharmaceuticals (USA) Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA200892 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121010 |
Package Information of ethosuximide
| Package NDC: | 68382-443-05 |
| Package Description: | 500 CAPSULE in 1 BOTTLE (68382-443-05) |
NDC Information of ethosuximide
| NDC Code | 68382-443-05 |
| Proprietary Name | ethosuximide |
| Package Description | 500 CAPSULE in 1 BOTTLE (68382-443-05) |
| Product NDC | 68382-443 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ethosuximide |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20121010 |
| Marketing Category Name | ANDA |
| Labeler Name | Zydus Pharmaceuticals (USA) Inc. |
| Substance Name | ETHOSUXIMIDE |
| Strength Number | 250 |
| Strength Unit | 1/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
